National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.12)
Instrument number PB 90 of 2011
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 24 November 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.12).
(2) This Determination may also be cited as PB 90 of 2011.
2 Commencement
This Determination commences on 1 December 2011.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Atazanavir
Insert
Asenapine
[2] Schedule 1, after item dealing with Colestipol
Insert
Corifollitropin alfa
[3] Schedule 1, after item dealing with Desvenlafaxine
Omit
Dexamethasone
[4] Schedule 1, after item dealing with Imiquimod
Insert
Indacaterol
[5] Schedule 1, after item dealing with Lithium
Insert
Losartan
[6] Schedule 1, after item dealing with Maraviroc
Insert
Magnesium
[7] Schedule 1, after item dealing with Telmisartan
Omit
Temozolomide
[8] Schedule 1, after item dealing with Thioguanine
Omit
Thiotepa
[9] Schedule 2, after item dealing with Desferrioxamine
Insert
Dexamethasone
[10] Schedule 2, after item dealing with Temazepam
Insert
Temozolomide
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.
